Francesco Galimi
Chief Tech/Sci/R&D Officer at ADICET BIO, INC.
Net worth: 184 260 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chen Schor | M | 51 |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | 8 years |
| Aya Jakobovits | M | 71 | 10 years | |
| Stewart Abbot | M | 57 |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | 6 years |
| Carl Gordon | M | 59 | 9 years | |
| Charles Holley | M | 67 | 7 years | |
| Steve Dubin | M | 70 | 4 years | |
| Katie Peng | F | 53 | 1 years | |
| Carrie Krehlik | F | 56 |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | 7 years |
| Jeffrey Chodakewitz | M | 68 | 4 years | |
| Anne Bowdidge | F | - | - | |
| Brian Druker | M | 68 | 6 years | |
| Andrew Sinclair | M | 52 | 3 years | |
| Wanda Austin | M | 69 | 7 years | |
| Brian Harvey | M | 63 | 4 years | |
| Michael Kauffman | M | 60 | 3 years | |
| Lori Johnston | F | 59 | 8 years | |
| Jonathan Graham | M | 63 | 9 years | |
| Ellen Kullman | F | 68 | 8 years | |
| Nancy L. Boman | M | - | 2 years | |
| Donald Healey | M | 62 | 4 years | |
| Murdo Gordon | M | - | 6 years | |
| Darryl Sleep | M | - | 6 years | |
| Nancy Grygiel | F | 56 | 9 years | |
| Blake Aftab | M | 43 | 3 years | |
| Amy Locke | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Kelly | M | 67 | 14 years | |
| Pamela Wapnick | F | 58 | 9 years | |
| Anil Singhal | M | 72 |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | 1 years |
| Madhavan Balachandran | M | 73 | 20 years | |
| Raymond C. Jordan | M | 70 | 7 years | |
| Nathan Hardy | M | 48 | 10 years | |
| Rosh Dias | M | - |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Patricia A. Turney | F | 57 | 23 years | |
| Sriram Ryali | M | 43 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Erin Lavelle | F | 46 | 15 years | |
| Joseph Newell | M | 54 | 7 years | |
| Robert Azelby | M | 56 | 5 years | |
| Yair Schindel | M | - | 1 years | |
| Sean E. Harper | M | 61 | 16 years | |
| Frank J. Biondi | M | 79 | 15 years | |
| Diana McKenzie | F | 59 | 12 years | |
| François de Carbonnel | M | 78 | 10 years | |
| Fred Hassan | M | 78 | 6 years | |
| Vance D. Coffman | M | 79 | 9 years | |
| David Baltimore | M | 86 | 21 years | |
| Judith C. Pelham | F | 78 | 22 years | |
| Donald Santel | M | 62 |
Adicet Therapeutics, Inc.
Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | 3 years |
| Bastiano Sanna | M | 49 | 3 years | |
| Mayank Mamtani | M | - | 2 years | |
| Zachary Roberts | M | 46 | - | |
| Feng Ye | M | 57 | 12 years | |
| Jeffrey Ludwig | M | 58 | 5 years | |
| Vanessa Broadhurst | F | 55 | 4 years | |
| Charles Wolfus | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
| Mark McClung | M | 61 | 4 years | |
| Lauren Lee | M | - | 2 years | |
| Richard Williams | M | 55 | 2 years | |
| Diana Landa | F | - | 2 years | |
| Erez Chimovits | M | 60 | 5 years | |
| Christopher J. DeRespino | M | 43 | 3 years | |
| Jeff Knight | M | 52 | 2 years | |
| Christopher Kirk | M | 52 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Daniel Mikol | M | - | 6 years | |
| William Richards | M | 63 | 23 years | |
| Becky Pferdehirt | M | - | 1 years | |
| Jane Chung | F | 53 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Roger Sidhu | M | 48 | 1 years | |
| Adrian Otte | M | - | 11 years | |
| Anat Nursella | F | - | - | |
| Goncagul Içören | F | 48 | 4 years | |
| Bill Tan | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 1 years |
| Cyrus Arman | M | 43 | 5 years | |
| Desmond Padhi | M | - | 1 years | |
| Peter Heerma | M | 53 | 4 years | |
| Anand Varadan | M | 57 | 16 years | |
| John Tsai | M | 57 | 1 years | |
| Yi Ning Zhao | M | 53 | 3 years | |
| Jerome Riebman | M | 70 | 2 years | |
| Marion McCourt | F | 64 | 3 years | |
| Michael Castagna | M | 47 | 4 years | |
| Wen Chen Yeh | M | 61 | 10 years | |
| James Ferguson | M | 70 | 3 years | |
| Catherine Stehman-Breen | M | 61 | 12 years | |
| Reshma Kewalramani | M | 51 | 13 years | |
| Brian Kotzin | M | 74 | 11 years | |
| Christopher Nardecchia | M | 62 | 11 years | |
| Asish Xavier | M | - | 1 years | |
| Svetlana Lucas | M | 52 | 1 years | |
| Kaye Foster-Cheek | F | 64 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Michael Wolfe | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Warren L. DeSouza | M | 55 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 9 years |
| Laura Hamill | F | 60 | 18 years | |
| Martina A. Sersch | M | 54 | 2 years | |
| Brian Sweeney | M | 59 | 15 years | |
| Andrew Hamer | M | 62 | 6 years | |
| Holger Wesche | M | 56 | 2 years | |
| Richard Paulson | M | 56 | 10 years | |
| Lloyd Klickstein | M | 67 | 2 years | |
| Jonathan Benjamin | M | - | 3 years | |
| Glen Burkhardt | M | 65 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Francesco Galimi
- Personal Network
